Navigation Links
REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011
Date:1/27/2011

DURECT will receive royalties for REMOXY and the other licensed drug candidates of between 6.0% to 11.5% of net sales of the drug candidate depending on sales volume as well as a mark-up on DURECT's supply of key excipients used in the manufacture of the licensed drug candidates.  Pain Therapeutics sublicensed the commercialization rights of REMOXY and other licensed drug candidates to King Pharmaceuticals in November 2005.  In October 2010, Pfizer Inc. (NYSE: PFE) announced that it had entered into a definitive merger agreement to acquire King.  Should that transaction be completed, Pfizer would assume the development and commercialization rights and obligations to REMOXY and to the other licensed ORADUR-based opioids.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR™, and TRANSDUR™-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR™, SABER™, ORADUR®, TRANSDUR™, and ELADUR™ are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.

DURECT Forward-Looking Statement

The statements in this press release regarding REMOXY, its poten
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. REMOXY® New Drug Application Resubmitted
2. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
3. Statement From Lilly on FDA Advisory Committee Recommendation Regarding Liprotamase New Drug Application for Treatment of Exocrine Pancreatic Insufficiency
4. K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™
5. CoreLab Partners Launches Advanced Imaging Application
6. Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices Offers Sessions on Orthopedic and Cardio Applications
7. BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application
8. Unilife Receives SPP Applications Exceeding A$12.8 Million
9. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
10. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
11. Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
(Date:2/27/2015)... MARLBOROUGH, Mass. , Feb. 27, 2015  Boston ... to participate in the Barclays 2015 Annual Healthcare Conference ... . Dan Brennan , executive vice ... , vice president, Investor Relations, will participate in a ... the host analyst at approximately 1:05 p.m. ET. Following ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... 2011 Misonix, Inc. (NASDAQ: MSON ... and markets innovative therapeutic ultrasonic products worldwide for ... surgery and other surgical and medical applications, announced ... Symposium on Advances in Skin and Wound Care ...
... Every year thousands of children are hospitalized — and ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Teens share stolen prescription ... pills that look like candy. In this ... can prevent harm by locking your medicine up. ...
Cached Medicine Technology:Misonix Exhibits at 26th Annual Clinical Symposium on Advances in Skin and Wound Care 2Misonix Exhibits at 26th Annual Clinical Symposium on Advances in Skin and Wound Care 3
(Date:2/27/2015)... 27, 2015 FACE Skincare~Medical~Wellness, a ... announced a unique combination to take fifteen years ... Décolletage is a new treatment introduced that is ... specifically indicated to improve lines and wrinkles on ... person who suffers from the stubborn vertical lines ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The UC ... research expertise have made it a beacon of hope ... beyond, has been acknowledged by the national society committed ... the Huntington’s Disease Society of America — as a ... The acknowledgement recognizes the center’s service to over 300 ...
(Date:2/27/2015)... Healthpointe is now performing arthroscopy ... or diseases affecting the elbow , wrist ... throughout Southern California, and are dedicated in providing ... related to the upper extremities. , Dr. ... board-certified and fully trained in treating an array ...
(Date:2/27/2015)... 27, 2015 Wimbledon Health ... provides vascular, echocardiogram and NCV testing with state-of-the-art ... preferred diagnostic testing provider for young athletes at ... liberal arts university in Milledgeville, Georgia. , ... U collegiate division, include a non-invasive vascular ...
(Date:2/27/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – is continuing to make its presence ... greater Miami area to host Swirl, A Wine Tasting ... Beach on Thursday, March 26, 2015. This year’s wine ...
Breaking Medicine News(10 mins):Health News:Face Skincare Announces New Combination Therapy 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 3Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2
... Michael McDowell has today insisted that he and his ... completely united within the Progressive Democrats Party and in ... of alleged reports that relationship between the two Cabinet ... the leader of the junior coalition partner. It was ...
... 200 people in the United States and the Far East ... lead to blindness. ,Investigators have warned contact lens ... warning has lead to the withdrawal of one type of ... of those affected. ,Researchers have also explained that ...
... University of Alabama biostatistician has compiled a report on that ... in this venture by 19 other scientists in the United ... more than 100 studies on the reasons for obesity besides ... be an answer ,* Inadequate sleep: Sleep deprivation ...
... educational facilities to enhance their knowledge base. // ... will be included in the first phase of the ... satellite for education launched in 2004. ,In ... and it will be subsequently introduced in private schools. ...
... a new set of dietary guidelines. Apart from the ... as U.S. Dietary Guidelines, the revised Food Guide Pyramid ... ,All the guidelines though are given by ... rules mentioned by all are increased intake of fruit ...
... their chances of breast cancer, a study says. ,Researchers ... Research on Cancer in France analysed 1,600 women. He found ... mutations who had undergone a chest X-ray were 54 percent ... never undergone the procedure. ,Women who were exposed ...
Cached Medicine News:Health News:Investigations Reveal That Infections Due To Contact lens Could Cause Blindness 2Health News:India's Northeast Students to Get Satellite-based Education Soon 2
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... We offer a complete ... bringing laboratorians state-of-the-art monoclonal and ... the detection of enteric pathogens ... includes products for Clostridium difficile, ...
... The C. Difficile Tox A/B II ... Professional Diagnostics's exclusive Fecal-Quik-Prep device which greatly ... stool specimens for Tox A/B II testing. ... preparation/transfer device that greatly reduces the amount ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
Medicine Products: